• Manish Kumar Jeenger, Shweta Shrivastava, Veera Ganesh Yerra, V G M Naidu, Sistla Ramakrishna, and Ashutosh Kumar.
• Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER)-Hyderabad, Bala Nagar, India.
• Nutrition. 2015 Feb 1; 31 (2): 276-82.

AbstractCurcumin is the major polyphenolic constituent of an indigenous herb, Curcuma longa, found to have a wide range of applications right from its kitchen use as a spicy ingredient to therapeutic and medicinal applications in various diseases. Curcumin has been identified to have a plethora of biologic and pharmacologic properties owing to its antioxidant and anti-inflammatory activities. This pleiotropic regulation of redox balance of cell and inflammation might be the basis of curcumin's beneficial activities in various pathologic conditions including diabetic complications. This review summarizes various in vitro, in vivo studies done on curcumin and its therapeutic utility in diabetic micro-vascular complications. This review also emphasizes the importance of curcumin in addition to the existing therapeutic modalities in diabetic complications. Copyright © 2015 Elsevier Inc. All rights reserved.

21 keywords...

hide…